We are live on ! Find out more
DOVA

Dova Pharmaceuticals, Inc. Common Stock
DOVA

Delisted

DOVA was delisted on the 11th of November, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Dova Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 72 → 0 (-72)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $278M → $0 (-$278M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 72

Holders
–
Holders Change
-72
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
72
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$104M
2
AAM
Alpine Associates Management
Florida
-$39.7M
3
BlackRock
BlackRock
New York
-$27.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$16.6M
5
GKIM
GW&K Investment Management
Massachusetts
-$9.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
– -$202K -7,214 Closed
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
– -$157K -5,600 Closed
Morgan Stanley
53
Morgan Stanley
New York
– -$148K -5,305 Closed
AIG
54
American International Group
New York
– -$147K -5,259 Closed
CG
55
Cutler Group
California
– -$97K -3,500 Closed
LTFS
56
Ladenburg Thalmann Financial Services
Florida
– -$79K -2,817 Closed
JP Morgan Chase
57
JP Morgan Chase
New York
– -$76K -2,731 Closed
Victory Capital Management
58
Victory Capital Management
Texas
– -$58K -2,084 Closed
TRCT
59
Tower Research Capital (TRC)
New York
– -$52K -1,876 Closed
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
– -$47.7K -1,707 Closed
Legal & General Group
61
Legal & General Group
United Kingdom
– -$35K -1,269 Closed
AIP
62
Ameritas Investment Partners
Nebraska
– -$28K -994 Closed
MAM
63
Meeder Asset Management
Ohio
– -$27K -988 Closed
DWA
64
Dorsey Wright & Associates
California
– -$19K -680 Closed
Royal Bank of Canada
65
Royal Bank of Canada
Ontario, Canada
– -$6K -213 Closed
Daiwa Securities Group
66
Daiwa Securities Group
Japan
– -$5K -183 Closed
PCG
67
Private Capital Group
Connecticut
– -$3K -113 Closed
AG
68
Advisor Group
Arizona
– -$1K -50 Closed
1 2
3

DOVA Hedge Fund Activity: Q4 2019 in Review

0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Dova Pharmaceuticals, Inc. Common Stock (DOVA) for Q4 2019, worth a combined $0 — down 100% from $278M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of DOVA and 0 opened new positions — a net loss of 72 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $104M sold.

  • 0 institutional investors held Dova Pharmaceuticals, Inc. Common Stock (DOVA) as of Q4 2019, down from 72 in Q3 2019.
  • Funds reported $0 of Dova Pharmaceuticals, Inc. Common Stock stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Dova Pharmaceuticals, Inc. Common Stock positions in Q4 2019 and 72 closed out, a net change of -72 holders.
  • The largest Dova Pharmaceuticals, Inc. Common Stock seller in Q4 2019 was Perceptive Advisors, an estimated $104M sold.

Based on aggregated 13F filings for Q4 2019.